Times Now · WorldNews · 2026-08-27
FDA Approves Drug For Advanced Pancreatic Cancer; Drug Nearly Doubles Survival
The US FDA has approved Rasonque, a once-daily targeted drug for metastatic pancreatic cancer, after a Phase 3 trial showed better patient survival. FDA Approves Drug For Advanced Pancreatic Cancer; Drug Nearly Doubles Survival The US FDA has approved Rasonque, a once-daily targeted drug for metastatic pancreatic cancer, after a Phase 3 trial showed better patient survival. , Health, Times Now
Read original on Times Now Get the app
Licensed summary · LicensedSummary
Related briefs
- MPSC Drug Inspector Exam Leak Case: Six Arrested After Entire Recruitment
- CIA director warned Russia not to attack NATO countries during Moscow trip
- Samay Raina Jokes About India's Got Latent Controversy As He Gets Felicitated
- 700 OpenAI AI Agents Went Rogue In Hugging Face Hack, Tried To Hide Their
- I Want To Fight For Every Shot': Suruchi Phogat Opens Up On Asian Games